<DOC>
	<DOC>NCT01080209</DOC>
	<brief_summary>This study will evaluate the biodegradation of the brimonidine tartrate posterior segment drug delivery system.</brief_summary>
	<brief_title>Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Received the most recent sham or active study treatment of intravitreal Brimo PS DDS® no later than 36 months prior to entry into this study and have either completed their previous study, or have exited early from their previous study for any reason Applicable studies: Previous Allergan intravitreal Brimo PS DDS® treatment studies None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>